Venclyxto®

Active substance

Venetoclax

Holder

AbbVie

Status

Closed

Indication

Treatment of chronic lymphocytic leukaemia in adult patients who are unsuitable for or have failed other treatments.

Public documents

Approbation

Information for the patient

Informed consent

Last update

15/12/2017

Last updated on 13/02/2024